Home » Topics » BioWorld Science

BioWorld Science
RSS

New phase II trial investigates JNJ-67864238 for moderate to severely active Crohn's disease

Oct. 28, 2019

Zosano initiates enrollment in phase II/III study of C-213 for cluster headache

Oct. 28, 2019

Molecular Targets meeting 2019: Bispecific matchmakers can improve antibodies, CARs

Oct. 28, 2019

Heat Biologics initiates first-in-human study of HS-130 with HS-110 in solid tumors

Oct. 28, 2019

Arcutis plans phase III program with ARQ-151 for plaque psoriasis

Oct. 28, 2019

Antimalarial agents detailed in UCB patent

Oct. 28, 2019

TaiMed Biologics discontinues development of TMB-607

Oct. 28, 2019

Y-mAbs announces presentation of data on naxitamab for neuroblastoma and osteosarcoma

Oct. 28, 2019

FUJIFILM synthesizes beta-lactams

Oct. 28, 2019

Merck & Co. presents new hSTING agonists

Oct. 28, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...